Panel Discussion: Focusing & Benchmarking the Antigen-Specific Immune Tolerance Space

Time: 8:30 am
day: Day Two


  • What Do the Next 12 Months Look Like?
  • Exploring safety considerations: Is there risk of activating a counter-regulatory immune response?
  • Discussing the most promising therapeutics in the landscape – what readouts do we expect in 2023?
  • Where is the field with novel technologies, and what must we understand to move forward?